ELAC2 — 1199 ClinVar variants
All ClinVar germline ELAC2 variants across every classification, each assembled from ClinVar, gnomAD, AlphaMissense, conservation and more. 404 flagged for review →
48 Pathogenic · 7 Pathogenic/Likely pathogenic · 26 Likely pathogenic · 27 Conflicting · 81 Benign · 8 Benign/Likely benign · 563 Likely benign · 439 Uncertain significance
Full ELAC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, constraint & interactions⚑ Evidence disagreements 404
Variants where the independent computational evidence doesn't line up with the clinical picture — a QC signal for a second look, not a reclassification.
Predictors vs ClinVar 3
ClinVar calls these pathogenic, but the computational predictors lean tolerated — the highest-value review flag.
-
ELAC2 p.Pro142Leu
Likely pathogenic
Single submitter
ovarian cancer
-
ELAC2 p.Thr57Ile
Likely pathogenic
Single submitter
ovarian cancer
-
ELAC2 p.Leu423Phe
Pathogenic
No assertion criteria
combined oxidative phosphorylation defect type 17
Predictors agree, ClinVar conflicts 9
ClinVar submitters conflict, but the independent predictors unanimously agree — a QC review flag, not a reclassification.
-
ELAC2 p.Arg675Gln
Conflicting
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Cys51Phe
Conflicting
Single submitter
Inborn genetic diseases
-
ELAC2 p.Glu174Lys
Conflicting
Single submitter
ovarian cancer
-
ELAC2 p.His226Arg
Conflicting
Single submitter
Inborn genetic diseases
-
ELAC2 p.Lys784Arg
Conflicting
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met750Thr
Conflicting
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ser17Leu
Conflicting
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ser490Ala
Conflicting
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Val642Met
Conflicting
Single submitter
prostate cancer, hereditary, 2
Predictors lean, ClinVar uncertain 202
ClinVar classifies these uncertain (VUS), but the independent predictors unanimously lean one way — a triage signal for review, not a reclassification. · showing the 150 best-reviewed of 202
-
ELAC2 p.Ala272Thr
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala344Thr
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg166Gly
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg33Leu
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg381His
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg404Cys
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg404His
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg630Gln
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg791Gln
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asn582Ser
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Cys87Arg
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln189Arg
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln594Glu
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln809Leu
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Glu149Lys
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu462Ala
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu97Asp
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Gly665Arg
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Gly802Ser
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His186Arg
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His223Arg
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His600Arg
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Ile396Val
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile775Asn
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu158Val
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Leu451Met
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu547Met
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Leu624Ser
Uncertain significance
Multiple submitters
prostate cancer, hereditary, 2
-
ELAC2 p.Leu7Val
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Lys384Met
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Lys45Arg
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Pro141Leu
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Pro171Leu
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Pro171Ser
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Thr667Ile
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Tyr75His
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Val241Ile
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Ala12Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala164Asp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala272Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala27Thr
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Ala333Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala333Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala335Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala3Gly
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala467Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala549Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala620Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
- ELAC2 p.Ala648Gly Uncertain significance Single submitter
-
ELAC2 p.Ala65Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala708Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala72Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala72Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala813Ser
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Arg202Gly
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg211Gln
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg231Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg235Gly
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg251Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg29Leu
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Arg404Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg430Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg465Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg477Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg497Gln
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg643Gln
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg643Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg728His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg797Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg812Gln
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asn218Asp
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Asn220Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asn220Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asn323Asp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
- ELAC2 p.Asn455Lys Uncertain significance Single submitter
-
ELAC2 p.Asn593Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp106Gly
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp280Asn
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp280Glu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp469Asn
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp550Tyr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp633Asn
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Cys311Ser
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Cys405Tyr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Cys421Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Cys441Trp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Cys516Tyr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Cys51Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln18Pro
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln198Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln230Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln418Lys
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gln452Arg
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gln458Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln468Arg
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gln479Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln479Pro
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gln590His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln61His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu699Ala
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu804Asp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly123Glu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly156Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly227Asp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly419Cys
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gly419Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly517Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly522Glu
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gly54Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly71Ala
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly801Asp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His194Pro
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.His248Gln
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His286Tyr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His551Asn
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
- ELAC2 p.His592Pro Uncertain significance Single submitter
- ELAC2 p.His644Tyr Uncertain significance Single submitter
-
ELAC2 p.Ile153Val
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Ile185Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile22Met
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile22Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile317Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile558Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile616Met
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu126Arg
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Leu412Ile
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Leu422Phe
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu628Pro
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Leu689Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu74Val
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Leu763Pro
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Lys45Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Lys608Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Lys646Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Lys660Ile
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Met16Ile
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met16Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met416Ile
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met604Ile
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Met668Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met676Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met721Ile
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met750Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met760Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met778Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met778Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met95Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Phe109Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Phe361Cys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Phe361Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
Predictors split 190
The independent predictors disagree with each other — read with care. · showing the 150 best-reviewed of 190
-
ELAC2 p.Ala277Thr
Uncertain significance
Multiple submitters
prostate cancer, hereditary, 2
-
ELAC2 p.Ala541Thr
Benign/Likely benign
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala549Thr
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Ala652Val
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala792Val
Uncertain significance
Multiple submitters
prostate cancer, hereditary, 2
-
ELAC2 p.Arg104Cys
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg360Trp
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg428Cys
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg428His
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg435Ser
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg464Trp
Benign/Likely benign
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg526His
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg675Trp
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg788Gln
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Arg812Trp
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asn107Asp
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Asn379Lys
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp509Asn
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp774Asn
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu622Gly
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu622Val
Benign/Likely benign
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu694Lys
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Glu741Lys
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly132Ala
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly132Arg
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly281Arg
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly303Val
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His383Asn
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His393Tyr
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile183Met
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu121Val
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Leu503Phe
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu569Val
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met494Thr
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Pro265Ala
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Pro299Thr
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Pro394Leu
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Pro572Leu
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Ser217Leu
Benign
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ser459Gly
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ser511Tyr
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ser52Phe
Likely benign
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Thr298Asn
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Thr440Ile
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Val348Met
Uncertain significance
Multiple submitters
Inborn genetic diseases
-
ELAC2 p.Val91Ile
Uncertain significance
Multiple submitters
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala3Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala450Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala450Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala565Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala607Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala717Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala73Glu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala792Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala820Gly
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ala820Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg104His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg112Gln
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Arg166Gln
Benign
Single submitter
ovarian cancer
-
ELAC2 p.Arg166Trp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
- ELAC2 p.Arg251Ser Uncertain significance Single submitter
-
ELAC2 p.Arg28Cys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg28His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg33His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg41Cys
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Arg46Cys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg526Cys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg564Cys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg630Gly
Likely benign
Single submitter
Inborn genetic diseases
-
ELAC2 p.Arg643Trp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg68Trp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg781Cys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg781His
Conflicting
Single submitter
Inborn genetic diseases
-
ELAC2 p.Arg781Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg785Trp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg788Trp
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Arg791Trp
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Arg812Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
- ELAC2 p.Asn371Ser Uncertain significance Single submitter
-
ELAC2 p.Asn390Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asn86Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp214His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp236Gly
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Asp313Asn
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Asp351Glu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp351Gly
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Asp35Asn
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gln182His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln366His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln388Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln789His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gln819His
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu145Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu176Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
- ELAC2 p.Glu176Val Uncertain significance Single submitter
-
ELAC2 p.Glu216Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu314Gly
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu322Gly
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Glu671Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu776Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Glu807Lys
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Glu817Lys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly13Glu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly303Ala
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly303Ser
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Gly529Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly53Cys
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Gly90Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His114Tyr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His223Tyr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His286Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His383Tyr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His39Gln
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His647Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His749Tyr
Conflicting
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.His98Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile396Phe
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile492Met
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile764Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Ile775Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu239Pro
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu370Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu391Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu399Arg
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu400Phe
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu40Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu559Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu560Gln
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu576Phe
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu577Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu599Pro
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu624Trp
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Leu74Phe
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu787Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu794Phe
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Leu795Pro
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Lys129Glu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
- ELAC2 p.Lys495Arg Uncertain significance Single submitter
-
ELAC2 p.Lys762Asn
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Lys822Thr
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met124Ile
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met178Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Met750Val
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Phe521Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Phe649Leu
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Phe80Leu
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Pro184Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
-
ELAC2 p.Pro273Ala
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Pro300Ser
Uncertain significance
Single submitter
Inborn genetic diseases
-
ELAC2 p.Pro336Ser
Uncertain significance
Single submitter
combined oxidative phosphorylation defect type 17
All ELAC2 variants
Pathogenic 48
- c.1423+1G>A Multiple submitters combined oxidative phosphorylation defect type 17
- p.Cys670fs Multiple submitters Inborn genetic diseases
- p.Gln18Ter Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ile153fs Multiple submitters combined oxidative phosphorylation defect type 17
- p.Phe154Leu Multiple submitters Prostate cancer, hereditary, 2, susceptibility to
- p.Ala11fs Single submitter combined oxidative phosphorylation defect type 17
- p.Arg43Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Arg630Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Cys136fs Single submitter combined oxidative phosphorylation defect type 17
- p.Cys311Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Cys405fs Single submitter combined oxidative phosphorylation defect type 17
- p.Gln330Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Gln356Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Gln479Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Gln727Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Gln92fs Single submitter combined oxidative phosphorylation defect type 17
- p.Gln96Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Glu174Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Glu176Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Glu290fs Single submitter combined oxidative phosphorylation defect type 17
- p.Glu622Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Gly288fs Single submitter combined oxidative phosphorylation defect type 17
- p.Gly47Ter Single submitter combined oxidative phosphorylation defect type 17
- p.His546fs Single submitter combined oxidative phosphorylation defect type 17
- p.His548Alafs Single submitter combined oxidative phosphorylation defect type 17
- p.His601fs Single submitter combined oxidative phosphorylation defect type 17
- p.His685fs Single submitter intellectual disability
- p.Leu100fs Single submitter combined oxidative phosphorylation defect type 17
- p.Leu128Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Leu133fs Single submitter combined oxidative phosphorylation defect type 17
- p.Leu513fs Single submitter combined oxidative phosphorylation defect type 17
- p.Leu569fs Single submitter combined oxidative phosphorylation defect type 17
- p.Leu576fs Single submitter combined oxidative phosphorylation defect type 17
- p.Met416fs Single submitter combined oxidative phosphorylation defect type 17
- p.Met760fs Single submitter combined oxidative phosphorylation defect type 17
- p.Pro26fs Single submitter combined oxidative phosphorylation defect type 17
- p.Ser736fs Single submitter combined oxidative phosphorylation defect type 17
- p.Thr365fs Single submitter combined oxidative phosphorylation defect type 17
- p.Trp115Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Trp357Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Tyr354Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Tyr75Ter Single submitter prostate cancer, hereditary, 2
- p.Val234fs Single submitter combined oxidative phosphorylation defect type 17
- p.Val256fs Single submitter combined oxidative phosphorylation defect type 17
- p.Val460fs Single submitter combined oxidative phosphorylation defect type 17
- p.Arg251Ter No assertion criteria combined oxidative phosphorylation defect type 17
- p.Leu423Phe No assertion criteria combined oxidative phosphorylation defect type 17 ⚠
- p.Thr520Ile No assertion criteria combined oxidative phosphorylation defect type 17
Pathogenic/Likely pathogenic 7
- c.245+2T>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.297-2_297-1delinsT Multiple submitters Inborn genetic diseases
- p.Arg497Ter Multiple submitters combined oxidative phosphorylation defect type 17
- p.Glu30Ter Multiple submitters combined oxidative phosphorylation defect type 17
- p.Glu482Ter Multiple submitters Inborn genetic diseases
- p.Met715fs Multiple submitters combined oxidative phosphorylation defect type 17
- p.Tyr425Ter Multiple submitters combined oxidative phosphorylation defect type 17
Likely pathogenic 26
- c.1080-1G>C Multiple submitters combined oxidative phosphorylation defect type 17
- c.1908+1G>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.1305-2A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1521-2A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1698+1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1699-1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1699-2A>G Single submitter Inborn genetic diseases
- c.1809-1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2029+1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2030-2A>G Single submitter combined oxidative phosphorylation defect type 17
- c.2109-6_2111del Single submitter combined oxidative phosphorylation defect type 17
- c.246-2A>G Single submitter combined oxidative phosphorylation defect type 17
- c.367+2T>C Single submitter combined oxidative phosphorylation defect type 17
- c.432+1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.738+1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.739-1G>C Single submitter combined oxidative phosphorylation defect type 17
- c.797+1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.984-2A>G Single submitter combined oxidative phosphorylation defect type 17
- p.Ala648Val Single submitter combined oxidative phosphorylation defect type 17
- p.Glu310Ala Single submitter combined oxidative phosphorylation defect type 17
- p.Met343Arg Single submitter combined oxidative phosphorylation defect type 17
- p.Pro142Leu Single submitter ovarian cancer ⚠
- p.Pro300del Single submitter
- p.Pro493Leu Single submitter
- p.Thr57Ile Single submitter ovarian cancer ⚠
- c.2254-2A>G No assertion criteria ELAC2-related disorder
Conflicting classifications of pathogenicity 27
- c.1305-8_1305-7insTCTC Single submitter combined oxidative phosphorylation defect type 17
- c.1808+15C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2253+1G>C Single submitter combined oxidative phosphorylation defect type 17
- c.560-2A>G Single submitter combined oxidative phosphorylation defect type 17
- c.680-11T>G Single submitter combined oxidative phosphorylation defect type 17
- c.871-11del Single submitter combined oxidative phosphorylation defect type 17
- p.Ala65= Single submitter combined oxidative phosphorylation defect type 17
- p.Arg211Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Arg675Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg781His Single submitter Inborn genetic diseases ⚠
- p.Arg785_Asp805dup Single submitter Inborn genetic diseases
- p.Cys51Phe Single submitter Inborn genetic diseases ⚠
- p.Gln523Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Glu174Lys Single submitter ovarian cancer ⚠
- p.His226Arg Single submitter Inborn genetic diseases ⚠
- p.His749Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Lys784Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Met750Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ser116Phe Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ser17Leu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ser217= Single submitter combined oxidative phosphorylation defect type 17
- p.Ser490Ala Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ser507= Single submitter combined oxidative phosphorylation defect type 17
- p.Ser52Cys Single submitter Inborn genetic diseases ⚠
- p.Thr639Ala Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Trp197Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Val642Met Single submitter prostate cancer, hereditary, 2 ⚠
Benign 81
- c.1079+72G>C Multiple submitters
- c.1218+15C>T Multiple submitters prostate cancer, hereditary, 2
- c.1304+17A>T Multiple submitters prostate cancer, hereditary, 2
- c.1305-225G>A Multiple submitters
- c.1305-337G>A Multiple submitters
- c.1305-6dup Multiple submitters combined oxidative phosphorylation defect type 17
- c.1305-8T>C Multiple submitters prostate cancer, hereditary, 2
- c.1305-9_1305-8insCTC Multiple submitters combined oxidative phosphorylation defect type 17
- c.1520+41C>T Multiple submitters
- c.1659+138T>C Multiple submitters
- c.1808+26G>C Multiple submitters combined oxidative phosphorylation defect type 17
- c.1809-75G>T Multiple submitters
- c.2108+14G>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.2108+73G>A Multiple submitters
- c.2109-145T>G Multiple submitters
- c.2253+171C>G Multiple submitters
- c.297-11T>C Multiple submitters combined oxidative phosphorylation defect type 17
- c.432+105C>T Multiple submitters
- c.433-43C>T Multiple submitters
- c.490+206G>A Multiple submitters
- c.491-14T>C Multiple submitters prostate cancer, hereditary, 2
- c.559+136G>A Multiple submitters
- c.679+146T>G Multiple submitters
- c.679+148G>A Multiple submitters
- c.679+185C>G Multiple submitters
- c.679+60T>C Multiple submitters
- c.680-36A>G Multiple submitters
- c.739-208C>T Multiple submitters
- c.798-20G>T Multiple submitters prostate cancer, hereditary, 2
- c.983+102A>G Multiple submitters
- c.983+59A>T Multiple submitters
- c.984-132C>T Multiple submitters
- c.984-204C>G Multiple submitters
- c.984-237T>C Multiple submitters
- c.984-237T>G Multiple submitters
- c.*151C>G Multiple submitters
- c.*206C>T Multiple submitters
- c.*280T>A Multiple submitters
- c.*320G>A Multiple submitters
- p.Pro493= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ser217Leu Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Ser710= Multiple submitters prostate cancer, hereditary, 2
- p.Thr631= Multiple submitters prostate cancer, hereditary, 2
- p.Tyr463= Multiple submitters prostate cancer, hereditary, 2
- c.1080-236del Single submitter
- c.1080-326T>C Single submitter
- c.1304+65del Single submitter
- c.1423+239C>T Single submitter
- c.1423+308C>T Single submitter
- c.1424-16A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1424-284C>A Single submitter
- c.1424-6del Single submitter combined oxidative phosphorylation defect type 17
- c.1424-6dup Single submitter combined oxidative phosphorylation defect type 17
- c.1520+182dup Single submitter
- c.1521-258del Single submitter
- c.1699-8dup Single submitter combined oxidative phosphorylation defect type 17
- c.1808+229T>C Single submitter
- c.1808+233G>C Single submitter
- c.1809-252C>T Single submitter
- c.1809-5del Single submitter combined oxidative phosphorylation defect type 17
- c.1908+8del Single submitter combined oxidative phosphorylation defect type 17
- c.2254-191G>A Single submitter
- c.2254-211G>A Single submitter
- c.367+116del Single submitter
- c.367+117G>T Single submitter
- c.367+95dup Single submitter
- c.433-241G>A Single submitter
- c.433-296T>C Single submitter
- c.433-305T>C Single submitter
- c.490+277T>C Single submitter
- c.491-170T>G Single submitter
- c.491-253del Single submitter
- c.679+9A>G Single submitter combined oxidative phosphorylation defect type 17
- c.738+241G>A Single submitter
- c.870+21_870+23dup Single submitter
- c.871-188_871-183del Single submitter
- c.871-316A>T Single submitter
- c.-381A>G Single submitter
- c.-408C>T Single submitter
- p.Ala3= Single submitter combined oxidative phosphorylation defect type 17
- p.Arg166Gln Single submitter ovarian cancer ⚠
Benign/Likely benign 8
- c.1305-8delinsCTCTC Multiple submitters combined oxidative phosphorylation defect type 17
- c.368-4T>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.797+14del Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ala541Thr Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg464Trp Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg564= Multiple submitters prostate cancer, hereditary, 2
- p.Glu622Val Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Pro32Arg Multiple submitters combined oxidative phosphorylation defect type 17
Likely benign 563
Showing the top 300 by review status; the full set is in the sitemap.
- c.1079+91C>T Multiple submitters
- c.1080-177C>T Multiple submitters
- c.1659+258A>G Multiple submitters
- c.1908+16G>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.2108+13G>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.2108+54G>C Multiple submitters
- c.2109-17C>G Multiple submitters combined oxidative phosphorylation defect type 17
- c.2254-8T>C Multiple submitters combined oxidative phosphorylation defect type 17
- c.245+238C>T Multiple submitters
- c.367+7A>G Multiple submitters combined oxidative phosphorylation defect type 17
- c.432+7C>T Multiple submitters combined oxidative phosphorylation defect type 17
- c.559+168A>T Multiple submitters
- c.559+16A>G Multiple submitters combined oxidative phosphorylation defect type 17
- c.738+17G>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.983+9G>A Multiple submitters combined oxidative phosphorylation defect type 17
- c.*33G>T Multiple submitters
- p.Ala11= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ala467= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ala717= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ala792= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Asp280= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Asp469= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Cys525= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Gln819= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Glu97= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Gly123= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Gly801= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ile775= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Leu40= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Leu486= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Leu803= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Pro508= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ser52Phe Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Thr179= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Thr387= Multiple submitters combined oxidative phosphorylation defect type 17
- p.Tyr75= Multiple submitters combined oxidative phosphorylation defect type 17
- c.1079+13G>C Single submitter combined oxidative phosphorylation defect type 17
- c.1079+14C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1079+16C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1079+19C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1079+20G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1080-12G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1080-16dup Single submitter combined oxidative phosphorylation defect type 17
- c.1080-16G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1080-16G>C Single submitter combined oxidative phosphorylation defect type 17
- c.1080-17G>C Single submitter combined oxidative phosphorylation defect type 17
- c.1080-18G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1080-19C>G Single submitter combined oxidative phosphorylation defect type 17
- c.1080-19C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1080-20C>A Single submitter combined oxidative phosphorylation defect type 17
- c.1080-20C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1080-257A>G Single submitter
- c.1080-276G>A Single submitter
- c.1080-5C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1080-8C>A Single submitter combined oxidative phosphorylation defect type 17
- c.1080-8C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1218+11A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1218+11A>T Single submitter combined oxidative phosphorylation defect type 17
- c.1218+12G>C Single submitter combined oxidative phosphorylation defect type 17
- c.1218+16G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1218+19C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1218+20C>A Single submitter combined oxidative phosphorylation defect type 17
- c.1218+20C>G Single submitter combined oxidative phosphorylation defect type 17
- c.1218+20C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1218+27G>A Single submitter
- c.1218+8C>G Single submitter combined oxidative phosphorylation defect type 17
- c.1218+8C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1219-12T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1219-17T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1304+13T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1304+15del Single submitter combined oxidative phosphorylation defect type 17
- c.1304+15G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1304+15G>C Single submitter combined oxidative phosphorylation defect type 17
- c.1304+212C>T Single submitter
- c.1304+9C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1305-10C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1305-11_1305-8del Single submitter combined oxidative phosphorylation defect type 17
- c.1305-12_1305-11insCTCT Single submitter
- c.1305-12C>G Single submitter combined oxidative phosphorylation defect type 17
- c.1305-12C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1305-14C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1305-16CT[6] Single submitter
- c.1305-20G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1305-8_1305-7insTC Single submitter combined oxidative phosphorylation defect type 17
- c.1423+116T>C Single submitter
- c.1423+11G>T Single submitter combined oxidative phosphorylation defect type 17
- c.1423+13C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1423+152T>C Single submitter
- c.1423+167G>T Single submitter
- c.1423+19A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1423+208G>A Single submitter
- c.1423+7G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1423+8G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1423+9G>T Single submitter combined oxidative phosphorylation defect type 17
- c.1424-12A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1424-15T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1424-17C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1424-5dup Single submitter combined oxidative phosphorylation defect type 17
- c.1424-6T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1520+7T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1520+9C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1521-16C>G Single submitter combined oxidative phosphorylation defect type 17
- c.1521-20C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1521-24CT[2] Single submitter combined oxidative phosphorylation defect type 17
- c.1521-259_1521-258del Single submitter
- c.1521-274dup Single submitter
- c.1659+116T>G Single submitter
- c.1659+12G>C Single submitter combined oxidative phosphorylation defect type 17
- c.1659+12G>T Single submitter combined oxidative phosphorylation defect type 17
- c.1659+13del Single submitter combined oxidative phosphorylation defect type 17
- c.1659+20A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1659+7G>T Single submitter combined oxidative phosphorylation defect type 17
- c.1659+8T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1660-10T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1660-10T>G Single submitter combined oxidative phosphorylation defect type 17
- c.1660-17T>G Single submitter combined oxidative phosphorylation defect type 17
- c.1660-18C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1660-263A>G Single submitter
- c.1660-5G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1660-9C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1698+18T>G Single submitter combined oxidative phosphorylation defect type 17
- c.1698+20G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1699-12T>G Single submitter combined oxidative phosphorylation defect type 17
- c.1699-15C>A Single submitter combined oxidative phosphorylation defect type 17
- c.1699-15C>G Single submitter combined oxidative phosphorylation defect type 17
- c.1699-16G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1699-19C>G Single submitter combined oxidative phosphorylation defect type 17
- c.1699-20A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1808+14del Single submitter combined oxidative phosphorylation defect type 17
- c.1808+7A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1809-10C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1809-12G>C Single submitter combined oxidative phosphorylation defect type 17
- c.1809-14T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1809-14T>G Single submitter combined oxidative phosphorylation defect type 17
- c.1809-150T>C Single submitter
- c.1809-19A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1809-8T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1908+11_1908+12del Single submitter combined oxidative phosphorylation defect type 17
- c.1908+16G>T Single submitter combined oxidative phosphorylation defect type 17
- c.1908+20G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1908+7G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1908+8G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1908+9C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1909-11C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1909-14C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1909-15G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1909-15G>T Single submitter combined oxidative phosphorylation defect type 17
- c.1909-16A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1909-18C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1909-20del Single submitter combined oxidative phosphorylation defect type 17
- c.1909-8C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2029+10G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2029+11G>T Single submitter combined oxidative phosphorylation defect type 17
- c.2029+19A>C Single submitter combined oxidative phosphorylation defect type 17
- c.2030-12C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2030-15G>T Single submitter combined oxidative phosphorylation defect type 17
- c.2030-18del Single submitter combined oxidative phosphorylation defect type 17
- c.2030-3del Single submitter combined oxidative phosphorylation defect type 17
- c.2030-4C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2030-6C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2108+12C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2108+14_2108+16dup Single submitter combined oxidative phosphorylation defect type 17
- c.2108+8del Single submitter combined oxidative phosphorylation defect type 17
- c.2108+9G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2109-15G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2109-18T>C Single submitter combined oxidative phosphorylation defect type 17
- c.2109-19C>G Single submitter combined oxidative phosphorylation defect type 17
- c.2109-201C>G Single submitter
- c.2109-6C>T Single submitter
- c.2109-9C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2253+14_2253+15del Single submitter combined oxidative phosphorylation defect type 17
- c.2253+15C>A Single submitter combined oxidative phosphorylation defect type 17
- c.2253+15C>G Single submitter combined oxidative phosphorylation defect type 17
- c.2253+15C>T Single submitter combined oxidative phosphorylation defect type 17
- c.2253+16G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2253+20A>G Single submitter combined oxidative phosphorylation defect type 17
- c.2253+29C>T Single submitter
- c.2253+317G>A Single submitter
- c.2254-11G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2254-12T>C Single submitter combined oxidative phosphorylation defect type 17
- c.2254-13T>C Single submitter combined oxidative phosphorylation defect type 17
- c.2254-14A>G Single submitter combined oxidative phosphorylation defect type 17
- c.2254-16C>G Single submitter combined oxidative phosphorylation defect type 17
- c.2254-36C>G Single submitter
- c.2254-5T>G Single submitter combined oxidative phosphorylation defect type 17
- c.2254-6T>C Single submitter combined oxidative phosphorylation defect type 17
- c.2254-9G>C Single submitter combined oxidative phosphorylation defect type 17
- c.245+10C>T Single submitter combined oxidative phosphorylation defect type 17
- c.245+14C>A Single submitter combined oxidative phosphorylation defect type 17
- c.245+14C>T Single submitter combined oxidative phosphorylation defect type 17
- c.245+17C>A Single submitter combined oxidative phosphorylation defect type 17
- c.245+18G>T Single submitter combined oxidative phosphorylation defect type 17
- c.245+19C>A Single submitter combined oxidative phosphorylation defect type 17
- c.245+20C>T Single submitter combined oxidative phosphorylation defect type 17
- c.245+9A>G Single submitter combined oxidative phosphorylation defect type 17
- c.246-14T>C Single submitter combined oxidative phosphorylation defect type 17
- c.246-15A>C Single submitter combined oxidative phosphorylation defect type 17
- c.246-18G>A Single submitter combined oxidative phosphorylation defect type 17
- c.246-19T>C Single submitter combined oxidative phosphorylation defect type 17
- c.246-20G>C Single submitter combined oxidative phosphorylation defect type 17
- c.246-7C>A Single submitter combined oxidative phosphorylation defect type 17
- c.246-89del Single submitter
- c.246-8T>C Single submitter combined oxidative phosphorylation defect type 17
- c.246-9G>A Single submitter combined oxidative phosphorylation defect type 17
- c.296+10T>C Single submitter combined oxidative phosphorylation defect type 17
- c.296+11C>G Single submitter combined oxidative phosphorylation defect type 17
- c.296+11C>T Single submitter combined oxidative phosphorylation defect type 17
- c.296+13_296+14del Single submitter combined oxidative phosphorylation defect type 17
- c.296+3_296+6dup Single submitter combined oxidative phosphorylation defect type 17
- c.296+9G>A Single submitter combined oxidative phosphorylation defect type 17
- c.297-10T>G Single submitter combined oxidative phosphorylation defect type 17
- c.297-14T>G Single submitter combined oxidative phosphorylation defect type 17
- c.297-16G>A Single submitter combined oxidative phosphorylation defect type 17
- c.297-4T>C Single submitter combined oxidative phosphorylation defect type 17
- c.297-5del Single submitter combined oxidative phosphorylation defect type 17
- c.297-8A>G Single submitter combined oxidative phosphorylation defect type 17
- c.297-9C>A Single submitter combined oxidative phosphorylation defect type 17
- c.297-9C>T Single submitter combined oxidative phosphorylation defect type 17
- c.367+12C>T Single submitter combined oxidative phosphorylation defect type 17
- c.367+15del Single submitter combined oxidative phosphorylation defect type 17
- c.367+15T>C Single submitter combined oxidative phosphorylation defect type 17
- c.367+19G>A Single submitter combined oxidative phosphorylation defect type 17
- c.368-10T>C Single submitter combined oxidative phosphorylation defect type 17
- c.368-11A>G Single submitter combined oxidative phosphorylation defect type 17
- c.368-12C>T Single submitter combined oxidative phosphorylation defect type 17
- c.368-7T>A Single submitter combined oxidative phosphorylation defect type 17
- c.432+10T>C Single submitter combined oxidative phosphorylation defect type 17
- c.432+11C>T Single submitter combined oxidative phosphorylation defect type 17
- c.432+12del Single submitter combined oxidative phosphorylation defect type 17
- c.432+15A>C Single submitter combined oxidative phosphorylation defect type 17
- c.432+17A>C Single submitter combined oxidative phosphorylation defect type 17
- c.432+18C>T Single submitter combined oxidative phosphorylation defect type 17
- c.433-16C>T Single submitter combined oxidative phosphorylation defect type 17
- c.433-20A>G Single submitter combined oxidative phosphorylation defect type 17
- c.433-5A>G Single submitter combined oxidative phosphorylation defect type 17
- c.433-5A>T Single submitter combined oxidative phosphorylation defect type 17
- c.490+11G>C Single submitter combined oxidative phosphorylation defect type 17
- c.490+13C>T Single submitter combined oxidative phosphorylation defect type 17
- c.490+18A>G Single submitter combined oxidative phosphorylation defect type 17
- c.491-11T>C Single submitter combined oxidative phosphorylation defect type 17
- c.491-18TG[4] Single submitter combined oxidative phosphorylation defect type 17
- c.491-20G>C Single submitter combined oxidative phosphorylation defect type 17
- c.491-31A>G Single submitter
- c.491-4G>T Single submitter combined oxidative phosphorylation defect type 17
- c.491-53_491-37dup Single submitter
- c.491-5T>C Single submitter combined oxidative phosphorylation defect type 17
- c.491-6T>C Single submitter combined oxidative phosphorylation defect type 17
- c.559+12del Single submitter combined oxidative phosphorylation defect type 17
- c.559+17G>C Single submitter combined oxidative phosphorylation defect type 17
- c.559+18G>A Single submitter combined oxidative phosphorylation defect type 17
- c.559+61G>A Single submitter
- c.559+7A>G Single submitter combined oxidative phosphorylation defect type 17
- c.559+8T>C Single submitter combined oxidative phosphorylation defect type 17
- c.560-12T>C Single submitter combined oxidative phosphorylation defect type 17
- c.560-15A>G Single submitter combined oxidative phosphorylation defect type 17
- c.560-20G>A Single submitter combined oxidative phosphorylation defect type 17
- c.560-293G>A Single submitter
- c.560-6G>A Single submitter combined oxidative phosphorylation defect type 17
- c.679+11A>G Single submitter combined oxidative phosphorylation defect type 17
- c.679+14C>G Single submitter combined oxidative phosphorylation defect type 17
- c.679+16_679+20del Single submitter combined oxidative phosphorylation defect type 17
- c.679+236G>A Single submitter
- c.680-12G>C Single submitter combined oxidative phosphorylation defect type 17
- c.680-14G>A Single submitter combined oxidative phosphorylation defect type 17
- c.680-169G>A Single submitter
- c.680-16G>C Single submitter combined oxidative phosphorylation defect type 17
- c.680-19C>G Single submitter combined oxidative phosphorylation defect type 17
- c.680-4T>G Single submitter combined oxidative phosphorylation defect type 17
- c.680-6C>T Single submitter combined oxidative phosphorylation defect type 17
- c.738+12T>A Single submitter combined oxidative phosphorylation defect type 17
- c.738+13T>C Single submitter combined oxidative phosphorylation defect type 17
- c.738+14T>G Single submitter combined oxidative phosphorylation defect type 17
- c.738+15C>G Single submitter combined oxidative phosphorylation defect type 17
- c.738+16C>T Single submitter combined oxidative phosphorylation defect type 17
- c.738+7A>C Single submitter combined oxidative phosphorylation defect type 17
- c.738+9G>C Single submitter combined oxidative phosphorylation defect type 17
- c.739-11C>T Single submitter combined oxidative phosphorylation defect type 17
- c.739-15T>C Single submitter combined oxidative phosphorylation defect type 17
- c.739-18A>G Single submitter combined oxidative phosphorylation defect type 17
- c.739-20C>G Single submitter combined oxidative phosphorylation defect type 17
- c.739-275G>A Single submitter
- c.739-4G>T Single submitter combined oxidative phosphorylation defect type 17
- c.797+13G>A Single submitter combined oxidative phosphorylation defect type 17
- c.797+16A>G Single submitter combined oxidative phosphorylation defect type 17
- c.797+20C>T Single submitter combined oxidative phosphorylation defect type 17
- c.797+8_797+9del Single submitter combined oxidative phosphorylation defect type 17
- c.797+8T>C Single submitter combined oxidative phosphorylation defect type 17
- c.797+8T>G Single submitter combined oxidative phosphorylation defect type 17
- c.797+9G>A Single submitter combined oxidative phosphorylation defect type 17
- c.797+9G>C Single submitter combined oxidative phosphorylation defect type 17
- c.797+9G>T Single submitter combined oxidative phosphorylation defect type 17
- c.798-13C>G Single submitter combined oxidative phosphorylation defect type 17
- c.798-19C>T Single submitter combined oxidative phosphorylation defect type 17
- c.798-7A>G Single submitter combined oxidative phosphorylation defect type 17
- c.870+11T>C Single submitter combined oxidative phosphorylation defect type 17
- c.871-17C>T Single submitter combined oxidative phosphorylation defect type 17
- c.871-18G>A Single submitter combined oxidative phosphorylation defect type 17
- c.871-18G>T Single submitter combined oxidative phosphorylation defect type 17
- c.871-20G>A Single submitter combined oxidative phosphorylation defect type 17
- c.871-7T>C Single submitter combined oxidative phosphorylation defect type 17
Uncertain significance 439
Showing the top 300 by review status; the full set is in the sitemap.
- c.1080-3C>T Multiple submitters combined oxidative phosphorylation defect type 17
- p.Ala272Thr Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Ala277Thr Multiple submitters prostate cancer, hereditary, 2 ⚠
- p.Ala344Thr Multiple submitters Inborn genetic diseases ⚠
- p.Ala549Thr Multiple submitters Inborn genetic diseases ⚠
- p.Ala652Val Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Ala792Val Multiple submitters prostate cancer, hereditary, 2 ⚠
- p.Arg104Cys Multiple submitters Inborn genetic diseases ⚠
- p.Arg166Gly Multiple submitters Inborn genetic diseases ⚠
- p.Arg29Phe Multiple submitters combined oxidative phosphorylation defect type 17
- p.Arg33Leu Multiple submitters Inborn genetic diseases ⚠
- p.Arg360Trp Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg381His Multiple submitters Inborn genetic diseases ⚠
- p.Arg404Cys Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg404His Multiple submitters Inborn genetic diseases ⚠
- p.Arg428Cys Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg428His Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg435Ser Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg477del Multiple submitters Inborn genetic diseases
- p.Arg526His Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg630Gln Multiple submitters Inborn genetic diseases ⚠
- p.Arg675Trp Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg788Gln Multiple submitters Inborn genetic diseases ⚠
- p.Arg791_Ala792insGlnValArg Multiple submitters Inborn genetic diseases
- p.Arg791Gln Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Arg812Trp Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Asn107Asp Multiple submitters Inborn genetic diseases ⚠
- p.Asn379Lys Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Asn582Ser Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Asp509Asn Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Asp774Asn Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Cys87Arg Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Gln189Arg Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Gln594Glu Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Gln809Leu Multiple submitters Inborn genetic diseases ⚠
- p.Glu149Lys Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Glu462Ala Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Glu622Gly Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Glu694Lys Multiple submitters Inborn genetic diseases ⚠
- p.Glu741Lys Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Glu97Asp Multiple submitters Inborn genetic diseases ⚠
- p.Gly132Ala Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Gly132Arg Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Gly281Arg Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Gly303Val Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Gly665Arg Multiple submitters Inborn genetic diseases ⚠
- p.Gly802Ser Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.His186Arg Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.His223Arg Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.His383Asn Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.His393Tyr Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.His600Arg Multiple submitters Inborn genetic diseases ⚠
- p.Ile183Met Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Ile396Val Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Ile775Asn Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Leu121Val Multiple submitters Inborn genetic diseases ⚠
- p.Leu158Val Multiple submitters Inborn genetic diseases ⚠
- p.Leu451Met Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Leu503Phe Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Leu547Met Multiple submitters Inborn genetic diseases ⚠
- p.Leu569Val Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Leu624Ser Multiple submitters prostate cancer, hereditary, 2 ⚠
- p.Leu7Val Multiple submitters Inborn genetic diseases ⚠
- p.Lys384Met Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Lys45Arg Multiple submitters Inborn genetic diseases ⚠
- p.Met494Thr Multiple submitters Inborn genetic diseases ⚠
- p.Pro141Leu Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Pro171Leu Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Pro171Ser Multiple submitters Inborn genetic diseases ⚠
- p.Pro265Ala Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Pro299Thr Multiple submitters Inborn genetic diseases ⚠
- p.Pro394Leu Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Pro572Leu Multiple submitters Inborn genetic diseases ⚠
- p.Ser459Gly Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Ser511Tyr Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Thr298Asn Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Thr440Ile Multiple submitters Inborn genetic diseases ⚠
- p.Thr667Ile Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- p.Tyr75His Multiple submitters Inborn genetic diseases ⚠
- p.Val241Ile Multiple submitters Inborn genetic diseases ⚠
- p.Val348Met Multiple submitters Inborn genetic diseases ⚠
- p.Val91Ile Multiple submitters combined oxidative phosphorylation defect type 17 ⚠
- c.1218+5T>C Single submitter combined oxidative phosphorylation defect type 17
- c.1424-3C>T Single submitter combined oxidative phosphorylation defect type 17
- c.1424-9T>G Single submitter combined oxidative phosphorylation defect type 17
- c.1659+2dup Single submitter combined oxidative phosphorylation defect type 17
- c.1659+3G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1659+5G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1698+1G>C Single submitter prostate cancer, hereditary, 2
- c.1698+5G>A Single submitter combined oxidative phosphorylation defect type 17
- c.1808+4A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1908+3A>G Single submitter combined oxidative phosphorylation defect type 17
- c.1908+5G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2029+5G>A Single submitter combined oxidative phosphorylation defect type 17
- c.2030-11T>C Single submitter combined oxidative phosphorylation defect type 17
- c.2108+1G>A Single submitter
- c.2253+6_2253+321del Single submitter combined oxidative phosphorylation defect type 17
- c.297-3T>A Single submitter combined oxidative phosphorylation defect type 17
- c.432+1del Single submitter combined oxidative phosphorylation defect type 17
- c.490+5G>A Single submitter combined oxidative phosphorylation defect type 17
- c.560-10T>C Single submitter combined oxidative phosphorylation defect type 17
- c.560-18G>A Single submitter combined oxidative phosphorylation defect type 17
- c.560-1G>A Single submitter combined oxidative phosphorylation defect type 17
- c.680-3C>T Single submitter combined oxidative phosphorylation defect type 17
- c.739-13_739-9del Single submitter combined oxidative phosphorylation defect type 17
- c.797+11G>C Single submitter combined oxidative phosphorylation defect type 17
- c.870+4A>T Single submitter Inborn genetic diseases
- c.871-10G>A Single submitter combined oxidative phosphorylation defect type 17
- c.871-3C>T Single submitter combined oxidative phosphorylation defect type 17
- c.983+6G>C Single submitter combined oxidative phosphorylation defect type 17
- c.-2G>T Single submitter
- p.Ala12Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala164Asp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala272Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala27Thr Single submitter Inborn genetic diseases ⚠
- p.Ala333Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala333Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala335Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala3Gly Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala3Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala450Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala450Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala467Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala549Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala565Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala607Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala620Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala648Gly Single submitter ⚠
- p.Ala65Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala708Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala717Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala72Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala72Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala73Glu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala792_Leu794delinsVal Single submitter combined oxidative phosphorylation defect type 17
- p.Ala792Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala813Ser Single submitter Inborn genetic diseases ⚠
- p.Ala820Gly Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ala820Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg104His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg112Gln Single submitter Inborn genetic diseases ⚠
- p.Arg166Trp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg202Gly Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg211Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg231Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg235Gly Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg251Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg251Ser Single submitter ⚠
- p.Arg28Cys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg28His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg29Leu Single submitter Inborn genetic diseases ⚠
- p.Arg33His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg404Leu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg41Cys Single submitter Inborn genetic diseases ⚠
- p.Arg430Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg465del Single submitter combined oxidative phosphorylation defect type 17
- p.Arg465Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg46Cys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg477Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg497Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg526Cys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg564Cys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg643Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg643Leu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg643Trp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg68Trp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg728His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg781Cys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg781Leu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg785Trp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg788Trp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg791Trp Single submitter Inborn genetic diseases ⚠
- p.Arg797Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg812Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg812Leu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Arg824fs Single submitter combined oxidative phosphorylation defect type 17
- p.Asn218Asp Single submitter Inborn genetic diseases ⚠
- p.Asn220Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asn220Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asn323Asp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asn371Ser Single submitter ⚠
- p.Asn390Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asn455Lys Single submitter ⚠
- p.Asn593Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asn86Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp106Gly Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp214His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp236Gly Single submitter Inborn genetic diseases ⚠
- p.Asp280Asn Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp280Glu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp313Asn Single submitter Inborn genetic diseases ⚠
- p.Asp351Glu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp351Gly Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp35Asn Single submitter Inborn genetic diseases ⚠
- p.Asp469Asn Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp550Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp633Asn Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Asp756fs Single submitter combined oxidative phosphorylation defect type 17
- p.Asp805_Gly806insArgGlyLeuArgGlnValArgAlaAlaLeuLeuSerArgGluLeuAlaGlyGlyLeuGluAsp Single submitter combined oxidative phosphorylation defect type 17
- p.Cys311Ser Single submitter Inborn genetic diseases ⚠
- p.Cys374Leu Single submitter combined oxidative phosphorylation defect type 17
- p.Cys405Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Cys421Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Cys441Trp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Cys516Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Cys51Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln182His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln18Pro Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln198Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln230Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln366His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln388Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln418Lys Single submitter Inborn genetic diseases ⚠
- p.Gln452Arg Single submitter Inborn genetic diseases ⚠
- p.Gln458Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln468Arg Single submitter Inborn genetic diseases ⚠
- p.Gln479Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln479Pro Single submitter Inborn genetic diseases ⚠
- p.Gln590His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln61His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln789His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln819His Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gln819Ter Single submitter combined oxidative phosphorylation defect type 17
- p.Glu145Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu176Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu176Val Single submitter ⚠
- p.Glu216Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu314Gly Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu322Gly Single submitter Inborn genetic diseases ⚠
- p.Glu636= Single submitter combined oxidative phosphorylation defect type 17
- p.Glu671Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu699Ala Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu776Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu780_Glu783del Single submitter combined oxidative phosphorylation defect type 17
- p.Glu798Leu Single submitter combined oxidative phosphorylation defect type 17
- p.Glu798Ser Single submitter combined oxidative phosphorylation defect type 17
- p.Glu804Asp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Glu804fs Single submitter combined oxidative phosphorylation defect type 17
- p.Glu807Lys Single submitter Inborn genetic diseases ⚠
- p.Glu817del Single submitter combined oxidative phosphorylation defect type 17
- p.Glu817Lys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly123Glu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly13Glu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly156Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly19_Gln24del Single submitter combined oxidative phosphorylation defect type 17
- p.Gly227Asp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly233Lys Single submitter combined oxidative phosphorylation defect type 17
- p.Gly303Ala Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly303Ser Single submitter Inborn genetic diseases ⚠
- p.Gly419Cys Single submitter Inborn genetic diseases ⚠
- p.Gly419Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly517Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly522Glu Single submitter Inborn genetic diseases ⚠
- p.Gly529Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly53Cys Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly54Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly71Ala Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly801Asp Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Gly90Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His114Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His194Pro Single submitter Inborn genetic diseases ⚠
- p.His223Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His248Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His286Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His286Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His383Tyr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His39Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His551Asn Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His592Pro Single submitter ⚠
- p.His644Tyr Single submitter ⚠
- p.His647Leu Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.His98Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile153Val Single submitter Inborn genetic diseases ⚠
- p.Ile185Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile22Met Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile22Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile284del Single submitter combined oxidative phosphorylation defect type 17
- p.Ile317Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile396Phe Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile492Met Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile558Thr Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile616Met Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile764Ser Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Ile775Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu126Arg Single submitter Inborn genetic diseases ⚠
- p.Leu239Pro Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu370Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu391Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu399Arg Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu400Phe Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu40Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu412Ile Single submitter Inborn genetic diseases ⚠
- p.Leu422Phe Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu559Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu560del Single submitter combined oxidative phosphorylation defect type 17
- p.Leu560Gln Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu576Phe Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu577Val Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu599Pro Single submitter combined oxidative phosphorylation defect type 17 ⚠
- p.Leu624Trp Single submitter Inborn genetic diseases ⚠